30个月内药物暴露儿童的发育结局：贝利量表和贝利-II量表的比较

Developmental outcome of drug-exposed children through 30 months: a comparison of Bayley and Bayley-II.

作者信息

Schuler Maureen E, Nair Prasanna, Harrington Donna

机构信息

Department of Pediatrics, University of Maryland School of Medicine, 655 West Lombard Street, Suite 311, Baltimore, Maryland 21201, USA.

出版信息

Psychol Assess. 2003 Sep;15(3):435-8. doi: 10.1037/1040-3590.15.3.435.

DOI:10.1037/1040-3590.15.3.435

PMID:14593844

Abstract

This study examined the effects of the Bayley Scales of Infant Development (BSID) version on developmental outcomes among drug-exposed children, some of whom received an intervention. Developmental outcome was evaluated with the BSID at 12 and 18 months and with the BSID-II at 24 and 30 months. In the repeated measures analyses, children scored higher on the BSID Mental Developmental Index (MDI; p < .01) and Psychomotor Developmental Index (PDI; p < .01) than on the BSID-II MDI and PDI. Version x Time (p < .01) and Version x Group (p < .01) interactions were also found for the MDI but not the PDI. PDI scores decreased on both the BSID and the BSID-II (p < .01). Over the first 2 years postpartum, mean MDI and PDI scores decreased among these high-risk, drug-exposed children.

摘要

本研究考察了贝利婴儿发展量表（BSID）版本对药物暴露儿童发育结局的影响，其中一些儿童接受了干预。在12个月和18个月时用BSID评估发育结局，在24个月和30个月时用BSID-II评估。在重复测量分析中，儿童在BSID心理发展指数（MDI；p <.01）和心理运动发展指数（PDI；p <.01）上的得分高于在BSID-II MDI和PDI上的得分。还发现MDI存在版本×时间（p <.01）和版本×组（p <.01）的交互作用，但PDI不存在。BSID和BSID-II上的PDI得分均下降（p <.01）。在产后的头两年，这些高危药物暴露儿童的平均MDI和PDI得分下降。